compassionate cancer care For your best friend. Learn more
One Cure The answer to cancer may be walking right beside us. Learn more
Clinical Trials Providing hope for future cancer patients. About Clinical Trials
National Cancer Research Month Leading cancer discovery for 40 years. Learn more

One in four dogs and one in five cats will develop cancer in their lifetimes. Forty years ago, cancer was often a terminal diagnosis with few options, especially for pets. Today, there is hope.

The Flint Animal Cancer Center at Colorado State University offers a unique combination of advanced cancer diagnostic services, innovative treatment options, and compassionate care for dogs, cats, and other pets with cancer. As a patient, your pet will benefit from a comprehensive assessment provided by an expert, multidisciplinary team, including medical, surgical, and radiation oncologists. Each treatment plan is customized, and we work with you to determine the right course of action for your pet’s care.

We are a world leader in the treatment of dogs, cats, and pets with cancer, with nearly four decades of experience in providing leading-edge, comprehensive, and compassionate care.

Our goal is to make sure that you are fully informed about your pet’s diagnosis and treatment options, so you are comfortable asking questions and making decisions. You are a key member of your pet’s cancer care-giving team. Our clinical staff is committed to helping you understand your pet’s cancer treatment and will offer support every step of the way.

Our vision is to conquer cancer in all species.

Your gift is an investment in the Flint Animal Cancer Center's critical work to help pets and people with cancer. Together, we will find a cure. Donate Now

news and updates

read more

Companion Animals in the Face of a Cancer Diagnosis

The FACC has worked closely with the CU Cancer Center for more than twenty years. Together, we are partners in the world’s most advanced comparative oncology research program for pets and people. Last year, FACC director, Dr. Rod Page, and his CU counterpart, Dr. Richard Schulick, announced a new collaborative initiative that awarded a total […]

read more

Drs. Regan and Leibowitz Win V Foundation Grant for Pediatric Osteosarcoma Research

Collaboration has always been at the core of what we do at the Flint Animal Cancer Center, and we’re proud to have worked with the CU Cancer Center for more than 40 years. Together, we make up Colorado’s Cancer Center. And together, we’re collaborating to conquer cancer including by partnering on cutting-edge pediatric osteosarcoma research. […]

read more

Collaborating to Conquer Cancer

The Flint Animal Cancer Center has worked closely with the University of Colorado Cancer Center for more than two decades. Together, we are partners in the world’s most advanced comparative oncology research program. Through many collaborative projects, our scientists and clinicians work with their teams to develop new treatment strategies that can be rapidly and […]

read more
Latest News

FACC at Research Day 2023

The 24th Annual College of Veterinary Medicine and Biomedical Sciences Research Day was held on January 28, 2023. Research Day is a showcase of cutting-edge research projects and approaches from members of the College of Veterinary Medicine and Biomedical Sciences community. The annual symposium is an opportunity for students, faculty, and staff to present their […]

read more
Teaching and Learning

In Memory of Kelsey – A Lifetime of Contribution

Dogs are teachers in life and in death.  No truer words could be spoken about Kelsey Stuart, a beautiful Golden Retriever we had the honor of knowing at the Flint Animal Cancer Center.    In her nearly 15 remarkable years, Kelsey and her puppies have taught researchers so much about the genetic makeup of Golden Retrievers […]

flint animal cancer center newsletter

join our community

Be among the first to learn the latest Flint Animal Cancer Center news and pet cancer treatment information.
  • This field is for validation purposes and should be left unchanged.